Samsung Electronics plans to overhaul its smartphone strategy at the mid-range price point in order to appeal more to millennials, the company’s mobile CEO has told CNBC.
Mercedes-Benz is set to unveil its much-anticipated electric SUV on Tuesday, marking the start of a German onslaught against Tesla’s (TSLA.O) dominance of the fast-growing market for premium battery cars.
Verizon doesn’t sell its mobile phones or wireless plans over Amazon. Nor does it offer Fios, its high-speed internet service. But Verizon does advertise on Amazon.
CARACAS, Venezuela – President Nicolas Maduro said he is investing part of his personal savings in a gold-backed certificate as part of a much-questioned plan to crush hyperinflation and reactivate Venezuela’s moribund economy.
South Korea – Technological advantages over China rivals fuel growing demand for high-end vessels
Beijing, China – Chinese President Xi Jinping has announced a $60 billion package of aid, investment and loans to Africa, against a backdrop of growing concern about rising debt distress on the continent.
India – Google retains only a slight lead over Facebook in the competition for digital ad dollars in the crucial India market, sources familiar with the figures say, even though the search giant has been in the country far longer and has avoided the controversies that have dogged its rival.
WITH the recent positive news from the US and Mexico reaching a trade deal last week, the general sentiment of the market got a lift. US President Donald Trump said that he would terminate the existing Nafta (North American Free Trade Agreement) deal to go into this current new deal with Mexico.
Here’s another reason why investors need not worry much about an economic implosion.
Funding Circle, a British peer-to-peer lending marketplace, on Monday said it will list its shares on the London Stock Exchange’s main market, with Danish billionaire Anders Povlsen pledging to buy at last 10 percent of the company.
Jazz HER2 bispecific posts 59% survival at 30 months in gastric cancer
Pfizer sees weight gain in cancer patients, aims to enter phase 3 in 2025
‘Cooking with gas’: Regeneron sees its Opdualag rival as next big thing for treating solid tumors
IO Biotech’s vaccine and Keytruda combo hits primary endpoint in phase 2 squamous cell carcinoma trial
iTeos-GSK’s TIGIT combo shows 30% more tumor shrinkage than Jemperli, but safety signals scare investors
Eli Lilly sells Life Sciences Studio lab to Arctoris, moving automation platform from San Diego to Oxford
Biolexis enters oral GLP-1 horse race with preclinical study showing small molecule reduced weight of obese mice
AstraZeneca steps out from Daiichi’s shadow, posting data on ADC rivals to AbbVie, Pfizer
Wall Street Rises to Turn a Dismal Week Into Just a Bad One
Tesla Recalling Almost 700,000 Vehicles Due to Tire Pressure Monitoring System Issue
